GL Capital, Baiyunshan Heji Huangpu deal published by China's SAMR for simple case review
MLex Summary: The proposed acquisition by investment firm GL Capital of a 50 percent stake in Guangzhou Baiyunshan Heji Huangpu Traditional Chinese Medicine, a subsidiary of Guangzhou Baiyunshan Pharmaceutical Holdings, has...To view the full article, register now.
Already a subscriber? Click here to view full article